References
- Kim K, Jung S, Kim M, Park S, Yang HJ, Lee E. Global trends in the proportion of macrolide-resistant mycoplasma pneumoniae infections. JAMA Netw Open. 2022;5(7):e2220949. doi:10.1001/jamanetworkopen.2022.20949
- Tsai TA, Tsai CK, Kuo KC, Yu HR. Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children. J Microbiol Immunol. 2021;54(4):557–565.
- Rothstein TE, Cunningham SA, Rieke RA, Mainella JM, Mutchler MM, Patel R. Macrolide resistance in mycoplasma pneumoniae, midwestern United States, 2014 to 2021. Antimicrob Agents Chemother. 2022;66(4):e0243221. doi:10.1128/aac.02432-21
- Quan J, Langelier C, Kuchta A, et al. FLASH: a next-generation CRISPR diagnostic for multiplexed detection of antimicrobial resistance sequences. Nucleic Acids Res. 2019;47(14):e83. doi:10.1093/nar/gkz418
- Wang X, Li MZ, Luo M, et al. Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020. Emerg Microbes Infec. 2022;11(1):1508–1517. doi:10.1080/22221751.2022.2078228
- Fang MX, Weng X, Chen LY, et al. Fulminant central nervous system varicella-zoster virus infection unexpectedly diagnosed by metagenomic next-generation sequencing in an HIV-infected patient: a case report. BMC Infect Dis. 2020;20(1). doi:10.1186/s12879-020-4872-8
- Diao Z, Han D, Zhang R, Li J. Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections. J Adv Res. 2022;38:201–212. doi:10.1016/j.jare.2021.09.012
- Alishlash AS, Atkinson TP, Schlappi C, Leal SM, Waites KB, Xiao L. Mycoplasma pneumoniae carriage with de novo macrolide-resistance and breakthrough pneumonia. Pediatrics. 2019;144(4). doi:10.1542/peds.2019-1642
- Wang Q, Wang K, Zhang YB, et al. Neonatal Ureaplasma parvum meningitis: a case report and literature review. Transl Pediatr. 2020;9(2):174–179. doi:10.21037/tp.2020.02.04